Bay Colony Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
OIA
WIA
CCMG
Bay Colony Advisors's BTAL Position: Q3 2025 in Review
Bay Colony Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 36,090 shares — an estimated $639K sold.
Bay Colony Advisors first reported a position in BTAL in Q2 2023 and held it in 3 quarters. The position peaked at $1.06M in Q2 2023. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.
- Bay Colony Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
- Bay Colony Advisors sold 36,090 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $639K.
- Bay Colony Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q2 2023 and held it in 3 quarters.
- Bay Colony Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $1.06M in Q2 2023.
- 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.
Based on Bay Colony Advisors's 13F filing for Q3 2025, filed 24 Oct 2025.